Dana Investment Advisors Inc. Buys 75,546 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Dana Investment Advisors Inc. boosted its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 17.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 513,926 shares of the company’s stock after purchasing an additional 75,546 shares during the quarter. Dana Investment Advisors Inc. owned about 1.27% of Phibro Animal Health worth $8,619,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Wellington Management Group LLP grew its position in shares of Phibro Animal Health by 165.9% in the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock worth $1,908,000 after buying an additional 102,793 shares during the last quarter. Los Angeles Capital Management LLC purchased a new position in Phibro Animal Health in the first quarter worth $377,000. Bridge City Capital LLC increased its position in shares of Phibro Animal Health by 3.3% during the first quarter. Bridge City Capital LLC now owns 137,694 shares of the company’s stock worth $1,780,000 after purchasing an additional 4,433 shares in the last quarter. Cardinal Capital Management lifted its holdings in shares of Phibro Animal Health by 43.1% during the 1st quarter. Cardinal Capital Management now owns 53,507 shares of the company’s stock valued at $692,000 after purchasing an additional 16,112 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its position in shares of Phibro Animal Health by 78.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 81,608 shares of the company’s stock worth $1,055,000 after purchasing an additional 35,788 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Trading Up 2.0 %

Phibro Animal Health stock opened at $22.52 on Tuesday. The firm has a market cap of $912.13 million, a PE ratio of 70.38, a P/E/G ratio of 1.77 and a beta of 0.52. Phibro Animal Health Co. has a 12 month low of $9.40 and a 12 month high of $22.84. The stock’s 50 day simple moving average is $19.82 and its two-hundred day simple moving average is $17.33. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.07. The firm had revenue of $273.16 million during the quarter, compared to analyst estimates of $262.44 million. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. Analysts anticipate that Phibro Animal Health Co. will post 1.44 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Wednesday, September 4th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date was Wednesday, September 4th. Phibro Animal Health’s dividend payout ratio is presently 150.00%.

Insider Buying and Selling

In other Phibro Animal Health news, Director E Thomas Corcoran purchased 5,000 shares of the stock in a transaction that occurred on Wednesday, September 4th. The shares were purchased at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the transaction, the director now owns 25,000 shares of the company’s stock, valued at approximately $500,500. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 50.06% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on PAHC. JPMorgan Chase & Co. began coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price on the stock. Bank of America upped their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus price target of $15.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.